Preview of https://tinyurl.com/news-releases/pierre-fabre-laboratories-announces-the-submission-by-atara-biotherapeutics-of-tabelecleucel-tab-cel-biologics-license-application-for-treatment-of-epstein-barr-virus-positive-post-transplant-lymphoproliferative-disease-with-u-302151752.html

---

The preview feature requires cookies to be enabled in your web browser.